ERBITUX CETUXIMAB

USPTO USPTO 2002 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark ERBITUX CETUXIMAB was filed as Word and figurative mark on 09/10/2002 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 03/04/2008. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: May 21, 2018

Trademark form Word and figurative mark
File reference 76463019
Register number 3392234
Application date September 10, 2002
Publication date April 29, 2003
Entry date March 4, 2008

Trademark owner

180 Varick Street, 6th Floor
10014 New York
US

Trademark representatives

goods and services

5 PHARMACEUTICAL PREPARATION, NAMELY, MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER

ID: 1376463019